FDA to Evaluate Effectiveness of Brand-Name Drugs
The FDA announced a three year program to study safety and effectiveness of hundreds of nonprescription drugs. Panels will set standards for active ingredients labeling warnings and directions with the first review focusing on antacids and other OTC products.